Results 31 to 40 of about 261,516 (285)

Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans - a quantitative review [PDF]

, 2010
Background: Trans fatty acids are produced either by industrial hydrogenation or by biohydrogenation in the rumens of cows and sheep. Industrial trans fatty acids lower HDL cholesterol, raise LDL cholesterol, and increase the risk of coronary heart ...
Wanders Anne J., Brouwer, I.A.; id_orcid, Martijn B. Katan, Katan Martijn B., Martijn B Katan, Ingeborg A Brouwer, Anne J. Wanders, Brouwer, I.A., Katan, M.B.; id_orcid, Katan, M.B., Anne J Wanders, Wanders, A.J., Ingeborg A. Brouwer, Brouwer Ingeborg A.   +13 more
core   +1 more source

Non-HDL Cholesterol as a Measure of Atherosclerotic Risk

Journal of Atherosclerosis and Thrombosis, 2004
Elevated triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) levels, hallmarks of the atherogenic lipid profile found in the metabolic syndrome and type 2 diabetes, are commonly seen in Japanese patients with coronary heart disease (CHD).
Packard, Chris J., Saito, Yasushi
openaire   +3 more sources

Sex-specific associations between serum lipids and hemostatic factors: the cross-sectional population-based KORA-fit study

Lipids in Health and Disease, 2022
Background Studies on the associations between lipid parameters and different hemostatic factors in men and women from the general population are scarce.
Johannes Vogel von Falckenstein, Dennis Freuer, Annette Peters, Margit Heier, Daniel Teupser, Jakob Linseisen, Christa Meisinger   +6 more
doaj   +1 more source

Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults

Biomolecules & Biomedicine, 2022
Coronary artery disease (CAD) is uncommon in young adult patients. However, these patients have different risk factor profiles and high-risk coronary plaques are more common. The aim of this study was to examine the relations between the coronary plaque
Fatih Akin, İbrahim Altun, Burak Ayca, Nuri Kose, İlknur Altun   +4 more
doaj   +1 more source

Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital database

Indian Journal of Endocrinology and Metabolism, 2016
Objective: To determine gender differences and secular trends in total, low-density lipoprotein (LDL) and high DL (HDL) cholesterol and triglycerides using a large hospital database in India.
Rajeev Gupta, Madhawi Sharma, Neeraj Krishna Goyal, Preeti Bansal, Sailesh Lodha, Krishna Kumar Sharma   +5 more
doaj   +1 more source

Non-HDL Cholesterol

The Primary Care Companion to The Journal of Clinical Psychiatry, 2010
To the Editor: Cardiovascular disease (CVD) is estimated to be responsible for 50% of excess all-cause mortality in mentally ill persons. This high metabolic risk results in the life expectancy of individuals with mental health disorders being significantly reduced, as patients die up to 25 years earlier than the general population.1 Accelerated CVD
Ross A, Baker, Robert A, Forbes
openaire   +3 more sources

Measurement Uncertainty for Total Cholesterol, HDL-cholesterol, Triglycerides, Calculated LDL-cholesterol and non-HDL-cholesterol

, 2022
Ölçüm belirsizliği, bir sonucun kalitesinin kantitatif bir göstergesi olup, ölçüm sonuçlarının güvenilirlik düzeyinde gerçekleştirildiğini gösterir. Çalışmamızda laboratuvarımızda sık istenen testlerden olan total kolesterol (TK), HDL-kolesterol (HDL-K),
Korkmaz, Şeniz, Şeniz KORKMAZ
core   +1 more source

Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol

Journal of Cardiovascular Pharmacology and Therapeutics, 2023
Cardiovascular disease (CVD) caused by atherosclerosis is the leading cause of death worldwide. The level of low-density lipoprotein cholesterol (LDL-C), considered as the initiator of atherosclerosis, is the most widely used predictor for CVD risk and ...
Yonghong Luo MD, Daoquan Peng MD
doaj   +1 more source

Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias [PDF]

Current Cardiology Reports, 2018
The advent of combination therapy to provide LDL lowering beyond that achieved with statins necessitates the development of greater understanding of how drugs work together, what changes occur in key lipoprotein fractions, and what residual risk remains.Clinical trials of agents that, when added to statins, generate profound LDL lowering have been ...
openaire   +2 more sources

The cholesterol-raising diterpenes from coffee beans increase serum lipid transfer protein activity levels in humans [PDF]

, 1997
Cafestol and kahweol–diterpenes present in unfiltered coffee— strongly raise serum VLDL and LDL cholesterol and slightly reduce HDL cholesterol in humans. The mechanism of action is unknown.
de Roos, B, Tol, Aad, de Roos, B., de Jong-Caesar, R., Scheek, L.M., Urgert, R., Scheek, L. M., Gent, T, Caesar, R (Ruth), Gent, T. van, Katan, MB, Roos, B. de, van Tol, A., Jong-Caesar, R. de, van Gent, T., Tol, A. van, Scheek, LM (Leo), Urgert, R, Katan, M.B.; id_orcid, Katan, M.B.   +19 more
core   +1 more source